Cyrille Pauthenier graduated from “École Normale Supérieure” in Paris in both fundamental chemistry and biology with a focus on biomolecules modelling and engineering. In 2011 he specialized in Synthetic Biology participating, and he got his PhD in metabolic engineering methodology with a focus on retrieval of produced compounds at an industry viable scale. Cyrille co-founded the Abolis Biotechnologies company in 2014, with the aim of bringing state-of-the-art methodologies in metabolic engineering for the development of new micro-organism capable of producing chemical molecules using fermentation of renewable resources.

Cyrille Pauthenier

CEO, Abolis

ABOLIS

Also speaking: